Personal Journey Drives Cancer Innovation
Today’s oral cancer detection products typically rely on revealing abnormalities or detecting HPV. Yet these tests aren’t necessarily accurate or timely, discovering dangers.
Industry News
Companies Ink Deal for Oral Cancer Detection Products
Vigilant Biosciences has struck a three-year deal with Crown Dental + Medical Limited to distribute the OncAlert Oral Cancer Risk Assessment System in New Zealand..
- August 20, 2015
- 2 minutes read
